Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery
- 1Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 0Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Milrinone use significantly increases the risk of postoperative atrial fibrillation (AF) after cardiac surgery. This finding highlights a critical factor to consider in managing patients undergoing these procedures.
Area Of Science
- Cardiology
- Cardiac Surgery
- Pharmacology
Background
- Postoperative atrial fibrillation (AF) is a common complication following cardiac surgery, leading to increased morbidity and longer hospital stays.
- Inotropic drugs are frequently administered perioperatively to support cardiac function.
- The association between inotropic drug use and the development of postoperative AF requires further investigation.
Purpose Of The Study
- To investigate the hypothesis that inotropic drug administration is associated with an increased incidence of postoperative atrial fibrillation (AF).
Main Methods
- A cohort of 232 patients undergoing elective cardiac surgery was evaluated for perioperative risk factors.
- Data on patient demographics, comorbidities, surgical procedures, and perioperative medications were collected.
- Multivariable logistic regression analysis was employed to identify independent predictors of postoperative AF.
Main Results
- Postoperative atrial fibrillation (AF) developed in 28.9% of patients, associated with longer hospitalizations and increased mortality.
- Milrinone use was significantly linked to a higher risk of developing postoperative AF (58.2% vs. 26.1%).
- Independent predictors of AF included older age, lower ejection fraction, and milrinone use (OR 4.86).
Conclusions
- Milrinone is identified as an independent risk factor for the development of postoperative atrial fibrillation after elective cardiac surgery.
- These findings suggest that careful consideration of milrinone use in the perioperative period may be warranted to mitigate AF risk.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.